Dr. Qian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1600 E Jefferson St
Ste A1
Seattle, WA 98122Phone+1 206-320-2200Fax+1 206-320-2560- Is this information wrong?
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2007 - 2010
SSM St Mary's Hospital-St LouisInternship, Internal Medicine, 2006 - 2007
Shanghai Jiao Tong University School of MedicineClass of 1993
Certifications & Licensure
WA State Medical License 2012 - 2025
MO State Medical License Active through 2013- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 5 citationsHigh-dose vitamin Dsupplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial.Sandra D Cassard, Kathryn C Fitzgerald, Peiqing Qian, Susan A Emrich, Christina J Azevedo, Andrew D Goodman, Elizabeth A Sugar, Daniel Pelletier, Emmanuelle Waubant, E...> ;Eclinicalmedicine. 2023 May 1
- Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndromeKevin N. Alschuler, Daniel Whibley, Anna L. Kratz, Mark P. Jensen, Annette Wundes, Gloria von Geldern, Peiqing Qian, Charles H. Bombardier, Dawn M. Ehde> ;Journal of Neurology. 2021 Oct 19
- Exercise training and cognition in multiple sclerosis: The GET Smart trial protocol.Charles H. Bombardier, Robert W. Motl, Ralph H.B. Benedict, Nancy Temkin, Peiqing Qian, Katharine Alexander, Annabeth Evans, Andrea Thomas, Kristin Toms, Cathea M. Car...> ;Contemporary Clinical Trials. 2021 Feb 27
- Join now to see all
Press Mentions
ACTRIMS 2023: Most on Briumvi Show No MS Activity After 6 MonthsMarch 2nd, 2023- TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (Ublituximab) in Multiple Sclerosis to Be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual ForumFebruary 14th, 2023
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
Swedish Cherry Hill CampusSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
